Actinium Pharmaceuticals appoints Ajit Shetty to board
Dr. Shetty is a pharmaceutical industry executive with 36 years of experience at Johnson & Johnson (J&J) and its subsidiary Janssen.
Most recently Dr. Shetty served as the Head of Enterprise Supply Chain at J&J where he was responsible for the transformation and optimization of J&J’s global supply chain.
Dr. Shetty joined Janssen Pharmaceutica, Inc. in 1976 ultimately rising to the position of President in 1986 where he led the establishment of Janssen’s business in the U.S.
From 1999 to 2008 he was Managing Director of Janssen Pharmaceutica and from 2004 until 2012 he was Chairman of the Board of Directors. In Dr. Shetty’s most recent role at Johnson & Johnson he was head of Enterprise Supply Chain.
Dr. Shetty earned a Ph.D. in Metallurgy and B.A. Natural Sciences from Trinity College, Cambridge University and a Master of Business Administration from Carnegie Mellon University.
In 2007, he was bestowed the title of Baron by King Albert II of Belgium for his exceptional merits.
Dr. Shetty is a member of the Board of Trustees of Carnegie Mellon University, serves on the Board of Governors for GS1 (Global Standards) in Belgium and formerly served on the Corporate Advisory Board of the John Hopkins Carey Business School.
In 2016, he was named as Chairperson of the Vlaams Instituut voor Biotechnologie (VIB), a Belgium based life sciences research institute focused on translating scientific results into pharmaceutical, agricultural and industrial applications.
In addition, Dr. Shetty was elected Manager of the Year in 2004 in Flanders and received a Life-Time Achievement Award in India in 2010. ■
LATEST MOVES FROM New York
- Barnes & Noble Education appoints Michael P. Huseby as CEO
- Omnicom Group appoints Gracia Martore as director
- Bank of New York names Charles W. Scharf as CEO
- Sterling Bancorp appoints Christina M. Favilla as COO
- Interpublic Group names E. Lee Wyatt Jr. as independent director
More inside POST